Hormones and growth factors regulate telomerase activity in ageing and cancer

被引:91
作者
Bayne, S [1 ]
Liu, JP [1 ]
机构
[1] Monash Univ, AMREP, Mol Signalling Lab, Dept Immunol, Melbourne, Vic 3181, Australia
关键词
telomerase; cancer; ageing; hormones; growth factors;
D O I
10.1016/j.mce.2005.05.009
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Telomerase is a specialised reverse transcriptase that synthesises and preserves telomeres (the ends of chromosomes), thereby playing a key role in regulating the lifespan of cell proliferation. Telomerase activity is critically involved in cell development, ageing and tumourigenesis. Activation of telomerase to maintain telomeres is required for self renewal and proliferative expansion of a number of cell types, including stem cells, activated lymphocytes and cancerous cells. However, recent studies show that the safeguard mechanisms and the modes of regulation of telomerase are more revealing than thought under various physiological and pathological conditions. Considerable evidence suggests that hormones and growth factors are crucially involved in regulating telomerase activity and gene expression of telomerase reverse transcriptase (TERT). This review briefly summarises our current understanding of how hormones and growth factors regulate the telomerase and telomere network and how deregulation can induce ageing and related diseases such as cancer. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:11 / 22
页数:12
相关论文
共 128 条
  • [1] ALDOUS W, 1998, CANCER, V85, P1523
  • [2] Switching and signaling at the telomere
    Blackburn, EH
    [J]. CELL, 2001, 106 (06) : 661 - 673
  • [3] Telomerase beyond telomeres
    Blasco, MA
    [J]. NATURE REVIEWS CANCER, 2002, 2 (08) : 627 - 632
  • [4] Extended longevity in mice lacking the insulin receptor in adipose tissue
    Blüher, M
    Kahn, BB
    Kahn, CR
    [J]. SCIENCE, 2003, 299 (5606) : 572 - 574
  • [5] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [6] The effects of natural ligands of hormone receptors and their antagonists on telomerase activity in the androgen sensitive prostatic cancer cell line LNCaP
    Bouchal, J
    Kolár, Z
    Mad'arová, J
    Hlobilková, A
    von Angerer, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 63 (06) : 1177 - 1181
  • [7] Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity
    Brandt, S
    Heller, H
    Schuster, KD
    Grote, J
    [J]. LIVER INTERNATIONAL, 2004, 24 (01) : 46 - 54
  • [8] The genetics of human longevity
    Browner, WS
    Kahn, AJ
    Ziv, E
    Reiner, AP
    Oshima, J
    Cawthon, RM
    Hsueh, WC
    Cummings, SR
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 117 (11) : 851 - 860
  • [9] Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells
    Budiyanto, A
    Bito, T
    Kunisada, M
    Ashida, M
    Ichihashi, M
    Ueda, M
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (05) : 1088 - 1094
  • [10] Telomerase activity in normal and malignant mammalian tissues: Feasibility of telomerase as a target for cancer chemotherapy
    Burger, AM
    Bibby, MC
    Double, JA
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (04) : 516 - 522